Viewing Study NCT04394858


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:13 PM
Study NCT ID: NCT04394858
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-05-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module